Opendata, web and dolomites
H2020 projects about "anticancer"
The page lists 97 projects related to the topic "anticancer".
| # | |||
|---|---|---|---|
| 1 | SQUALAC | Preclinical development of squalenic acid and gemcitabine squalene nanomedicine | 2015 |
| 2 | MAGICBULLET | Peptide-Drug Conjugates for Targeted Delivery in Tumor Therapy | 2015 |
| 3 | GLYCANC | Matrix glycans as multifunctional pathogenesis factors and therapeutic targets in cancer | 2015 |
| 4 | NewSpindleForce | A new class of microtubules in the spindle exerting forces on kinetochores | 2015 |
| 5 | Leucophyl | Total Synthesis of Leucophyllidine | 2015 |
| 6 | BaCTher | Bacteria for Cancer Therapy | 2015 |
| 7 | MetalCell | Transition-Metal Mediated Chemistry in Cells | 2015 |
| 8 | PROVIST | PROTEASES VISUALIZATION DURING TUMOR PROGRESSION | 2016 |
| 9 | G4invivo | Probing intracellular folding and dynamics of telomeric DNA structures with single-molecule FRET | 2016 |
| 10 | CELLETEST | Liquid Biopsy blood test in lung cancer diagnosis and monitoring: a next generation noninvasive tumor tracker device | 2015 |
| 11 | MyNano | Towards the design of Personalised Polymer-based Combination Nanomedicines for Advanced Stage Breast Cancer Patients | 2015 |
| 12 | INPACT | Innovative peptides against cancer and pathogenic bacteria, with advances in science, biopharmaceutical drug development, product market targeting, training , and communication. | 2015 |
| 13 | TOPOmics | Global dynamics of topoisomerase-induced DNA breaks | 2015 |
| 14 | CellScreenChip | All-in-One Cell Screening Chip: Device for Affordable High-Throughput Cell Screenings | 2015 |
| 15 | Ocean Medicines | Ocean Medicines | 2015 |
| 16 | FORCE | Imaging the Force of Cancer | 2016 |
| 17 | PolyDrug Discovery | Discovery of anticancer polymeric drugs that mimic the action of TRAIL | 2016 |
| 18 | NoCanTher | Nanomedicine upscaling for early clinical phases of multimodal cancer therapy | 2016 |
| 19 | LATE-STAGE | Palladium catalyzed C(sp3)‒H late-stage diversification of biologically active molecules | 2016 |
| 20 | MTUB-ANGIO | Microtubule Dynamics during angiogenesis | 2016 |
| 21 | TiDrugArchitectures | Highly Competent and Safe Titanium(IV) Therapeutic Frameworks that are Cancer Targeted based on Complex 1, 2, and 3D Chemical Architectures | 2016 |
| 22 | iCARE | MobIle health-Care system for monitoring toxicity and symptoms in cAncer patients ReceivingdiseasE-oriented therapy | 2016 |
| 23 | REPLICONSTRAINTS | Dissecting the constraints that define the eukaryotic DNA replication program | 2016 |
| 24 | MarPipe | Improving the flow in the pipeline of the next generation of marine biodiscovery scientists | 2016 |
| 25 | PhotoMedMet | Towards Novel Inert (Photo-)toxic Ru(II) Polypyridyl Complexes | 2016 |
| 26 | EMbRACe | Effective Multidrug Cocktails for Cancer | 2016 |
| 27 | MULTIFUNSOME | Anti-EGFR Monoclonal Antibody Conjugated Thermoresponsive Liposome for Triple Negative Breast Cancer Thermo-Chemotherapy | 2017 |
| 28 | McHAP | Entrapment of Hypoxic Cancer by Macrophages Loaded with HAP | 2017 |
| 29 | SUMCASTEC | Semiconductor-based Ultrawideband Micromanipulation of CAncer STEm Cells | 2017 |
| 30 | ADJUV-ANT VACCINES | Elucidating the Molecular Mechanisms of Synthetic Saponin Adjuvants and Development of Novel Self-Adjuvanting Vaccines | 2017 |
| 31 | THUNDER | Development of the Cyclin-Dependent Kinase Inhibitor VS2-370 to Target HIV-associated Malignancies and to Purge Viral Reservoir | 2017 |
| 32 | PANTREAT | Pancreatic cancer as a treatment target of Dwarfbody-Therapeutics | 2017 |
| 33 | Targeting TopoII | Mechanistic studies of metal-dependent DNA cleavage in Type II topoisomerase toward therational design of novel anticancer drugs | 2017 |
| 34 | Anticancer-PAM | Anticancer activity of plasma activated medium and its underlying mechanisms: Combined experimental and computational study | 2017 |
| 35 | BRAINHIB | Integrated drug discovery approach to generate brain-penetrant inhibitors of glioblastoma cell proliferation | 2018 |
| 36 | TSPO METALLODRUGS | Novel, highly effective and selective anticancer metallodrugs | 2018 |
| 37 | PhoRAu | Photochemistry and radiolabelling of gold(III) anticancer prodrugs | 2018 |
| 38 | SHAPPI | Scaffold hybridization approach targeting PPIs | 2017 |
| 39 | PHOTORNA | Development of photoswitchable ligands for the reversible and selective assembly with RNA | 2017 |
| 40 | APACHE | Atmospheric Pressure plAsma meets biomaterials for bone Cancer HEaling | 2017 |
| 41 | DUALITY | An Integrated Computational and Experimental Approach to Rapid Synthesis of Highly Selective Dual-Targeted HDAC/CK2, MMP2/CK2 Inhibitors | 2018 |
| 42 | STARFISH DNA | Stalling the Replication Fork via the Impedimental Stabilization of Higher-order DNAs | 2017 |
| 43 | NanoMOFdeli | Design of NanoMOFs Capsules for Drug Delivery and Bioimaging. | 2017 |
| 44 | altEJrepair | Characterisation of DNA Double-Strand Break Repair by Alternative End-Joining: Potential Targets for Cancer Therapy | 2017 |
| 45 | SynPlex | Tailored chemical complexity through evolution-inspired synthetic biology | 2017 |
| 46 | AIDViC | Antibiotic intracellular delivery via virus-like carriers | 2017 |
| 47 | ZEBRAONCOFISH | Zebrafish avatar as a real-time in vivo platform for personalized cancer therapeutics | 2017 |
| 48 | TarMyc | Targeting the Oncogenic Function of Myc in vivo | 2018 |
| 49 | HypoRuLight | Hypoxic Tumour Models for Photoactivatable Ruthenium-based Chemotherapy | 2017 |
| 50 | NANONC | Nanomaterials in Oncology: Exploiting the Intrinsic Cancer-Specific Toxicity of Nanoparticles. | 2018 |
| 51 | NEOSETAC | New Selenium-based Targeted Nanocapsules to treat Breast Cancer | 2018 |
| 52 | CylcoRu4PACT | Cyclometallated ruthenium complexes for photo-activated chemotherapy | 2018 |
| 53 | NANOCARGO | Photo/magnetic stimulated nanocargos for superior cancer treatments | 2018 |
| 54 | CLINGLIO | A Clinical Phase IIB trial with 2OHOA in patients with newly-diagnosed malignant glioma. | 2017 |
| 55 | ToMeTuM | Towards the Understanding a Metal-Tumour-Metabolism | 2018 |
| 56 | INTERCELLMED | SENSING CELL-CELL INTERACTION HETEROGENEITY IN 3D TUMOR MODELS:TOWARDS PRECISION MEDICINE | 2018 |
| 57 | MicroBone | Novel 3D platforms to engineer bone microtissues for in vitro disease models | 2018 |
| 58 | CellularNanoMachines | Development of Stimuli-Responsive Nanoparticle-carrying T lymphocytes in the Fight against Cancer | 2019 |
| 59 | NEOTERP | Development of novel synthetic strategies for the synthesis of bioactive meroterpenoids | 2018 |
| 60 | Target5LO | Targeting 5-lipoxygenase in the context of Acute Myeloid Leukemia | 2018 |
| 61 | TheraSonix | Ultrasonic Imaging and Drug Propulsion Into Tumors Using Genetically Encoded Gas Nanostructures | 2018 |
| 62 | SPeNTa-Brain | Synthetic Peptidic Nanovesicles for Targeting Paediatric Brain tumours | 2019 |
| 63 | ORTHOCAT | Bioorthogonal Photocatalytic Activation of Metal-Based Prodrugs | 2018 |
| 64 | TRIANGLE | A novel integrative strategy to prevent colorectal cancer within the diet-host-microbiota triangle: from organoids to human in vivo reality | 2018 |
| 65 | SquaMem | Interaction of squalene-based anti-cancer and neuroprotective drugs with cell membranes: in silico study | 2018 |
| 66 | PPOM-PTT | New Peptide-Polyoxometalate Hybrids for Antimicrobial Photothermal Therapy | 2018 |
| 67 | THERACAT | Bio-orthogonal catalysis for cancer therapy | 2018 |
| 68 | SMARTRIOX | Disruptive targeted drug delivery system via synergistic combination of intelligent DNA molecular machines and gated mesoporous nanoparticles | 2018 |
| 69 | THERMONANO | Nanoassemblies for the subcutaneous self-administration of anticancer drugs | 2018 |
| 70 | ONCOSMART | ONCOlogic patient profiling and personalized treatment through SMART bedside diagnostics | 2018 |
| 71 | PIcelles | Penetration-promoting and Imageable Polymeric Micelles as a Platform Technology for Individualized and Improved Tumor-targeted Drug Delivery | 2018 |
| 72 | SusDrug | Sustainable Approach to Drug Discovery | 2019 |
| 73 | p38_InTh | Innovative therapeutic tools to ameliorate chemotherapy-induced cardiotoxicity | 2018 |
| 74 | BBBhybrid | Advanced in vitro physiological models: Towards real-scale, biomimetic and biohybrid barriers-on-a-chip | 2019 |
| 75 | ONCOFUM | Integrating the tissue-specificity and chronology of hereditary renal cancer predisposition | 2019 |
| 76 | PCinBC | Plasma cell heterogeneity and dynamics in patient tumors | 2019 |
| 77 | DC Metabolism | Metabolic Regulation of Conventional Dendritic Cell Development and Function | 2020 |
| 78 | MacrophInt | Targeting integrin signaling in tumour-associated macrophages to combat cancer progression and resistance | 2019 |
| 79 | BispecificsThatClick | Combinatorial Antibody Synthesis for the Discovery of New Anti-Tumour Immunomodulators | 2019 |
| 80 | MIMIC | Deciphering how microbiota modulate anti-tumor immune responses in checkpoint therapy | 2020 |
| 81 | Hyalcis | Hyaluronic-Cisplatin Film for Implant in Malignant Mesothelioma Recurrence | 2019 |
| 82 | GlycoMabs | Chemoenzymatic glyco-engineering of therapeutic monoclonal antibodies | 2019 |
| 83 | SCANRESIST | Reversal of anti-cancer drug resistance | 2019 |
| 84 | 3DBrainStrom | Brain metastases: Deciphering tumor-stroma interactions in three dimensions for the rational design of nanomedicines | 2019 |
| 85 | NETCONTROLOGY | Controllability of biological networks | 2020 |
| 86 | MABIOS | The first microalgae platform for the production of anticancer biopharmaceuticals | 2019 |
| 87 | Promitil | Promitil® - a new ‘smart’ nanomedicine for cancer chemo-radiotherapy. | 2019 |
| 88 | 3DCanPredict | Predicting clinical response to anticancer drugs using 3D-bioprinted tumor models for personalized therapy | 2019 |
| 89 | NoBiasFluors | Non-biased fluorescent dyes as markers of drugs for optical in cellulo and in vivo imaging | 2020 |
| 90 | ClickandTreatCancer | Ligand Directed NIR-based Theranostic Prodrugs for Prostate Cancer | 2020 |
| 91 | SynWaiXen | Total Synthesis of Waixenicin A and Xenibellol A | 2020 |
| 92 | BraINstorm | Engineered nanocarriers for simultaneous anticancer immune response and “switching” of tumor-associated macrophages for intranasal glioblastoma treatment | 2020 |
| 93 | TGF-BTB | Transforming Growth Factor – Bench To Bedside. Towards a better understanding of TGF-β isoform specific signalling in health and disease | 2020 |
| 94 | COMMiT | Cancer Organoids Multiplexed Screening in Microfluidic Textile chips | 2020 |
| 95 | COSMos | Chemistry of Sponge Microbiomes | 2020 |
| 96 | antiCSC | Targeting the cancer stem cell (CSC) metabolism with designed, reactive metal complexes | 2020 |
| 97 | EscaPI | Exploring the non-genetic (i.e. ePIgenetic) mechanisms that contribute to therapy Escape in melanoma | 2020 |